Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Nebraska Oncology Society
G

ES-SCLC 2020 Update: Which IO Options Showed Activity in Phase III Trials? How Effective Is Lurbinectedin in Stage IV Disease Progressed After 1L Therapy?

By Nebraska Oncology Society FEATURING Gregory Riely
By Nebraska Oncology Society FEATURING Gregory Riely
93 views
October 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

09:50
Incyte

Managing Chronic GVHD Master Class Series: Best Practices at 100 Day…

Feat. C. Cutler
Lung
19:56

The Non-Invasive Diagnosis of Lung Cancer

Memorial Sloan Kettering Cancer Center

G. Rocco

440 views
28:21

Role of Surgery in Locally Advanced NSCLC

Memorial Sloan Kettering Cancer Center

K. Gray

285 views
16:46

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance Systemic Therapy…

2024 ASCO® Annual Meeting Insights Hub

P. Iyengar

89 views
14:26

Radiation for Unresectable NSCLC: Where Are We Now and Where Are We …

Memorial Sloan Kettering Cancer Center

D. Gomez

149 views
26:21

NSCLC & Targeted Therapy: A Brief Overview and Update in the Metasta…

Memorial Sloan Kettering Cancer Center

M. Hwang

1.2K views
14:52

Advances in Resectable NSCLC

Memorial Sloan Kettering Cancer Center

K. Gray

151 views
09:38

ESMO 2023 Insights: "CDC7 Inhibition Constrains Lineage Plasticity a…

Insights from 2023 ESMO Annual Meeting

A. Quintanal-Villalonga

275 views
06:04

ESMO 2023 Insights: "Durable Efficacy of Zenocutuzumab, a HER2 x HER…

Insights from 2023 ESMO Annual Meeting

A. Schram

97 views
14:02

WCLC 2023 Insights: "MSI and MMR-D Define a Distinct Subset of Lung …

Insights from 2023 WCLC

S. Yang

125 views
10:18

Additional Advances in Squamous NSCLC Research and Clinical Trials

i3 Health

M. Kris

112 views
08:03
i3 Health

New Perspectives on Diagnosis and Treatment of EGFR Exon 20 Insertio…

Feat. H. Yu, M. Arcila
10:16

2021 ASCO Updates on KEYLYNK-013 Study for Newly Diagnosed LS-SCLC: …

Memorial Sloan Kettering Cancer Center

A. Rimner

256 views
05:59

2021 ASCO Updates on METex14 Skipping mNSCLC: ctDNA Dynamics & Resis…

Memorial Sloan Kettering Cancer Center

P. Paik

172 views
20:40

Can TTFields with Chemotherapy Improve Clinical Outcome in the First…

Memorial Sloan Kettering Cancer Center

C. Simone II

119 views
17:52

Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on A…

Memorial Sloan Kettering Cancer Center

M. Zauderer

273 views
16:53

Should We Combine EGFR TKIs With Upfront Radiation Therapy in EGFR+ …

Memorial Sloan Kettering Cancer Center

K. Beal

206 views
21:24

Is There a Role for IO in EGFR+ Metastatic Lung Cancer?

GRACE

H. Yu

4.8K views
19:58

Current Practice & Challenges in Execution of Genomic Testing in Adv…

Beacon Medical Interchange

J. West, G. Riely

321 views
28:12

Should Local Ablation Therapy in Oligometastatic or Oligoprogressing…

Beacon Medical Interchange

J. West, G. Riely

26 views
23:26

EGFR Initial Treatment and Acquired Resistance in Advanced NSCLC

GRACE

H. Yu

179 views
09:30

Q&A on EGFR Initial Treatment and Acquired Resistance in Advanced NS…

GRACE

H. Yu

34 views
07:39

ES-SCLC 2020 Update: Which IO Options Showed Activity in Phase III T…

Nebraska Oncology Society

G. Riely

93 views
16:08

Stage IV NSCLC 2020 Update: Is There a Benefit to Short-Course Chemo…

Nebraska Oncology Society

G. Riely

124 views